NCT02501018Phase 2Completed

Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)

Study sponsor: Lisata Therapeutics, Inc. · LSTA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-05-19Actual
Enrollment · participants33Actual
Source updated2024-10-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.